Objectives: A Japanese multicenter prospective cohort study examining endoscopic resection (ER) for early gastric cancer (EGC) has been conducted using a Web registry developed to determine the short-term and long-term outcomes based on absolute and expanded indications. We hereby present the short-term outcomes of this study.
examining endoscopic resection (ER) for early gastric cancer (EGC) has been conducted using a Web registry developed to determine the short-term and long-term outcomes based on absolute and expanded indications. We hereby present the short-term outcomes of this study.
Methods: All consecutive patients with EGC or suspected EGC undergoing ER at 41 participating institutions between July 2010 and June 2012 were enrolled and prospectively registered into the Web registry. The baseline characteristics were entered before ER, and the short-term outcomes were collected at 6 months following ER.
Results: Nine thousand six hundred and sixteen patients with 10 821 lesions underwent ER (endoscopic submucosal dissection [ESD] : 99.4%). The median procedure time was 76 min, and R0 resections were achieved for 91.6% of the lesions. Postoperative bleeding and intraoperative perforation occurred in 4.4% and 2.3% of the patients, respectively. Significant independent factors correlated with a longer procedure time (120 min or longer) were as follows: tumor size >20 mm, upper-third location, middle-third INTRODUCTION E NDOSCOPIC RESECTION (ER) of early gastric cancer (EGC) is performed based on two independent sets of indications: absolute indication and expanded indications. [1] [2] [3] ER procedures vary from conventional endoscopic mucosal resection (EMR) to endoscopic submucosal dissection (ESD). 4, 5 In particular, EGC lesions meeting the expanded indications were previously resected surgically because of the difficulty associated with the effective use of EMR techniques available at that time. However, following the development of ESD, en bloc resections can now be achieved even for EGC lesions meeting the expanded indications.
Recently, a number of reports have been published regarding the short-term and long-term outcomes of EMR and ESD for EGC, but most of these reports were retrospective studies from single centers. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] A Japanese multicenter prospective cohort study of ER for EGC using a Web registry system (J-WEB/EGC) has been conducted to determine the short-term and long-term outcomes based on the absolute and expanded indications. 25 In this report, we aimed to clarify the short-term outcomes of ER for EGC as a part of the secondary endpoints of the J-WEB/ EGC study.
METHODS

J-WEB/EGC design
T HE DESIGN OF the J-WEB/EGC has been previously reported. 25 Here, we briefly describe the design of the present study. We selected the 41 participating institutions to cover nearly all regions of Japan. All consecutive patients with EGC or suspected EGC undergoing ER at the participating institutions between July 2010 and June 2012 were included in the J-WEB/EGC study. A patient was excluded only if written informed consent was not obtained. All enrolled patients were prospectively registered in the Web registry system, and each patient was followed up for a minimum of 5 years. After the completion of 5 years of follow-up observation, additional 2 years are required to examine the outcomes of those patients whose present statuses are unknown. The J-WEB/EGC study is being conducted with the approval of the institutional review board of each participating institution. Written informed consent was required for the enrollment of each patient, and the study has been registered in the UMIN Clinical Trial Registry (UMIN000005871).
The investigation of the J-WEB/EGC study was divided into baseline patient and lesion characteristics as well as short-term and long-term outcomes. Baseline patient and lesion characteristics were entered using the Web registry system by each of the 41 participating institutions before the patients underwent ER. The short-term outcomes were entered using the Web registry system by each of the participating institutions at 6 months after ER. The long-term outcomes are being entered using the Web registry system by each of the participating institutions at 1, 3 and 5 years after ER. As for factors associated with a long procedure time, we analyzed the clinicopathological factors associated with a long procedure time using univariate and multivariate analyses.
Assessments in the present report
Definition of short-term outcomes of gastric ER
According to the Japanese classification of gastric carcinoma and the Japanese gastric cancer treatment guidelines, lesion characteristics and histopathological findings were evaluated. 1, 26 The macroscopic types were classified as elevated (0-I and 0-IIa), flat/depressed (0-IIc and 0-IIb) and combined (e.g. 0-IIa + IIc). The diagnosis of UL findings was made based on the presence of either active ulceration or an ulcer scar in both preoperative endoscopic examinations (clinical diagnosis) and pathological examinations (pathological diagnosis). During preoperative endoscopic examinations, active ulceration referred to open ulcers with adherent white exudate and excluded superficial erosions. 27 An ulcer scar was defined as mucosal folds or rugae converging at one point. Pathologically, an active ulcer was defined as a mucosal defect deeper than the muscularis mucosae. An ulcer scar was defined as a deformity of the muscularis propria and fibrosis in the submucosal or deeper layer. The histological type was defined according to the predominant histology of the lesion. Differentiated-type adenocarcinoma included tubular adenocarcinoma (well/moderately differentiated adenocarcinoma) and papillary adenocarcinoma, while undifferentiated-type adenocarcinoma included poorly differentiated adenocarcinoma, signet-ring cell adenocarcinoma, and mucinous adenocarcinoma. Infiltration of the submuscosa (SM) was subclassified as SM1 (<500 lm from the muscularis mucosae) or SM2 (≥500 lm from the muscularis mucosae). As for previous therapy, local recurrence was defined as a lesion detected at the site of an ER scar from a procedure performed prior to registration in this study.
The procedure time was defined as the time from insertion of the endoscope until its complete removal. A long ESD procedure time was defined as a procedure time of 120 min or longer according to previous reports. 5, 28 An en bloc resection was defined as a one-piece resection, and R0 resection was defined as en bloc resection with the HM and VM free from tumor. As for ER complications, postoperative bleeding was defined as clinical evidence of bleeding (hematemesis, melena, or a decrease in serum hemoglobin) requiring endoscopic treatment and occurring after an ER procedure. Intraoperative perforation was diagnosed endoscopically during ER, while delayed perforation was identified after the completion of ER, based on the presence of free air seen on an X-ray or computed tomography image and/or a gross defect observed endoscopically. Patients who underwent emergency surgery were defined as patients requiring emergency surgery because of ER complications.
According to the Japanese gastric cancer treatment guidelines, the following condition was evaluated to be a curative ER for the absolute indications: en bloc resection, tumor size of 20 mm or less, differentiated-type histological appearance, pT1a (M), HM (À), VM (À), UL (À), ly (À), and v (À). 1 The resection was considered to be a curative ER for the expanded indications when all of the following conditions were fulfilled: en bloc resection, HM (À), VM (À), ly (À), and v (À), with (i) tumor size greater than 20 mm, differentiated-type cancer, pT1a, UL (À), (ii) tumor size of 30 mm or smaller, differentiated-type cancer, pT1a, UL (+), (iii) tumor size of 20 mm or smaller, undifferentiated-type cancer, pT1a, UL (À), or (iv) tumor size of 30 mm or smaller, differentiatedtype cancer, pT1b (SM1). Resections that did not satisfy any of the above criteria were considered as noncurative ER.
Statistical analysis
The Chi-squared test was used for the univariate analyses to assess the clinicopathological factors associated with a long procedure time. We performed a multivariate logistic regression analysis to identify independent risk factors for a long procedure time. All the statistical analyses were performed using the statistical analysis software SPSS, version 20 (SPSS Japan Inc., Tokyo, Japan). A P-value <0.05 was considered statistically significant.
RESULTS
Patient flow chart and baseline characteristics
T HE PATIENT flow chart is shown in Figure 1 . A total of 9715 patients with 10 926 lesions who consented to participate in the J-WEB/EGC study were enrolled. Scheduled ERs were not performed in 99 patients with 105 lesions because of changes to other treatment plans after enrollment in the study (57 lesions: surgery, 37; observation, 13; and argon plasma coagulation [APC], seven) and the cancelation of ER after study enrollment because of a diagnosis of nonneoplastic lesions (35 lesions) or the development of another disease (13 lesions). Thus, a total of 9616 patients with 10 821 lesions underwent ER. ER was suspended during the procedure in six patients with six lesions because of complications during ER (four lesions: intraoperative bleeding, two; and intraoperative perforation, two) and the inability to dissect the SM layer because of severe fibrosis (two lesions). The ER procedures were completed in 9610 patients with 10 815 lesions. The baseline characteristics of the 9715 enrolled patients with 10 926 lesions are shown in Table 1 .
Outcomes and complications of ER
The ER outcomes (ESD: 99.4%, EMR: 0.6%) of the 9616 patients with 10 821 lesions are shown in Table 2 . The median procedure time was 76 min, and a long procedure time (120 min or longer) was required for 25.9% of the 10 821 lesions. An en bloc resection and R0 resection were achieved in 99.2% and 91.6% of the 10 821 lesions, respectively. Of the 9616 patients, postoperative bleeding was observed in 426 (4.4%), intraoperative perforation was observed in 218 (2.3%), and delayed perforation was observed in 40 (0.4%). Sixty-nine patients (0.7%) required a blood transfusion, and 23 patients (0.2%) underwent emergency surgery. Digestive
Factors associated with a long procedure time
Factors associated with a long procedure time are shown in 
achieved in 8195 lesions (81.7%). The numbers of lesions in each category of the ER indications are shown in Table 4 .
Outcomes of noncurative ER
The outcomes of lesions with noncurative ER are shown in Figure 2 . 
DISCUSSION
T HE J-WEB/EGC study is the first multicenter prospective study conducted in the context of 'real-world' settings to demonstrate a favorable short-term outcome for gastric ER (mostly ESD) among a large number of EGC lesions based on all categories of the absolute and expanded indications. 29 There are a number of published reports on the short-term and long-term outcomes of ESD for EGC, but most of the reports are retrospective studies from single centers. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] There were two multicenter prospective studies about the clinical outcomes of ESD for EGC; however, these multicenter prospective studies did not include all EGC lesions meeting the absolute and expanded indications. 23, 24 In this situation, to overcome these limitations, a Japanese multicenter prospective cohort study of ER for EGC using a Web registry system (J-WEB/EGC) was developed and introduced in July 2010. 25 In this report, the short-term outcomes of ER for EGC, such as the ER procedural outcomes, the factors associated with a long ER procedure time, and the clinical outcomes of noncurative gastric ER cases, were precisely evaluated by collecting an enormous amount of data from a very large number of EGC cases according to the common terminology criteria defined in the study protocol. In contrast, as for ER procedural outcomes and complications of previous retrospective studies that included 300 or more gastric ESD cases, the mean procedure time reportedly ranged from 37.5 to 93.9 min, and en bloc resections, R0 resections and curative resections were achieved in 91.1%-99.3%, 85.4-97.3%, and 73.6-94.3% of the cases, respectively. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] In addition, the risks of postoperative bleeding, intraoperative perforation, and delayed perforation were reportedly between 0% and 15.6%, 0.4%, and 5.3%, and 0.1% and 0.45%, respectively. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] 30, 31 These wide variations, especially those for the risks of complications, may be due to Differentiated, T1a (M), UL(-), ≤20 mm 5356 Differentiated, T1a (M), UL(-), >20 mm 1586 Differentiated, T1a (M), UL(+), ≤30 mm 610 Differentiated, T1b (SM1 † ), ≤30 mm 408 Undifferentiated, T1a (M), UL(-), ≤20 mm 235 † SM1 < 500 lm from the muscularis mucosae. ‡ SM2 ≥ 500 lm from the muscularis mucosae. HM, horizontal margin; IQR, interquartile range; Ly, lymphatic involvement; M, mucosa; SD, standard deviation; UL, ulcer; V, vascular involvement; VM, vertical margin. differences in the definitions of these outcomes among the studies.
Several studies have described factors associated with a long ER procedure time based on retrospective analyses. 5, 15, 28, 32, 33 In contrast, the J-WEB/EGC study is very important because this study is the only study to demonstrate the factors associated with a long ER procedure time in a prospective, large consecutive series of patients undergoing ER not only for EGC in the naive stomach but also for EGC in the remnant stomach/gastric tube and local recurrent EGC lesions, in accordance with the actual clinical settings. Similar to previous retrospective studies, our multivariate analysis showed that a larger tumor size (>20 mm), tumor location (upper-third and middle-third), and UL findings were significantly associated with a long ESD procedure time. 5, 15, 28, 32, 33 Additionally, this study demonstrated that a local recurrent lesion, gastric tube, male gender, and tumor depth (SM) were also significant predictors of a long ESD procedure time. The reason why local recurrent lesions were significantly associated with a long ER procedure time was thought to be the excessive submucosal fibrosis caused by prior ER procedures. We believe that the long ER procedure time for gastric tube lesions was attributable to the difficulty in visualizing the lesion margins and maneuvering the endoscope during ER caused by the long and narrow anatomic structure. The reason for the long ER procedure time in men may be related to sedation difficulties during ER. Male gender is reportedly associated with sedation difficulty during esophagogastroduodenoscopy. 34 In addition, the presence of submucosal fibrosis may have resulted in a long ER procedure time in patients with SM cancer.
Concerning the outcomes of noncurative ER, although several studies have described the clinical outcomes of noncurative gastric ER cases, most of these studies have assessed the clinical outcomes of noncurative gastric ER cases in small numbers of patients and without a detailed statistical analysis, with the exception of three previous studies from Kawata et al., Suzuki et al. and Hatta et al. [35] [36] [37] which included 500 or more noncurative gastric ESD cases. Hatta et al. 37 reported that among the 1064 cases undergoing a radical gastrectomy after noncurative ESD, LN metastasis was found in 89 patients (8.4%). This study was the only multicenter study to demonstrate the clinical outcomes of a large number of noncurative gastric ESD cases, but it was not a prospective study. In contrast, the J-WEB/EGC study is the only multicenter prospective study to demonstrate the clinical outcomes of noncurative gastric ESD cases. This nationwide multicenter prospective study demonstrated favorable short-term outcomes of gastric ESD using a very large number of EGC cases. However, these favorable short-term outcomes of gastric ESD may not be representative of all institutions in Japan, including lowvolume ESD centers, as most of the participating institutions in this study were high-volume ESD centers with numerous highly experienced endoscopists with specific expertise in ESD. Another limitation of this study is that data regarding the experiences of each endoscopist performing gastric ER are unavailable. Furthermore, this study did not perform a central review of the pathological evaluations.
In conclusion, this nationwide multicenter prospective cohort study showed favorable short-term outcomes of ESD for EGC in the context of real-world settings.
